|1.||Kalantar, Enayat: 1 article (01/2015)|
|2.||Abdollahi, Shadieh: 1 article (01/2015)|
|3.||Ramazanzadeh, Rashid: 1 article (01/2015)|
|4.||Khiabani, Zahra Delami: 1 article (01/2015)|
|5.||Perreten, Vincent: 1 article (10/2014)|
|6.||Wipf, Juliette R K: 1 article (10/2014)|
|7.||Schwendener, Sybille: 1 article (10/2014)|
|8.||Sahni, A K: 1 article (01/2014)|
|9.||Lall, Mahima: 1 article (01/2014)|
|10.||Zarazaga, Myriam: 1 article (07/2013)|
01/01/2015 - "Macrolide, lincosamide and streptogramin B (MLSB) are used in the treatment of staphylococcal infections. "
01/01/2014 - "Therapy for Staphylococcal infections may be complicated by the possibility of inducible macrolide-lincosamide-streptogramin B resistance (MLSBi). "
04/01/2012 - "Macrolide-lincosamide-streptogramin B (MLSB) group antibiotics are recommended as first choice in the treatment of staphylococcal infections. "
06/01/2012 - "The macrolide-lincosamide-streptogramin B (MLS(B)) groups of antibiotics are commonly used in the treatment of staphylococcal infections with clindamycin being the preferred agent. "
02/01/1995 - "Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus."
07/01/2000 - "Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics."
05/01/1997 - "The influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B (MLS(B)) type antibiotics (inducible MLS(B) phenotype) on the activity of quinupristin-dalfopristin was investigated against Enterococcus faecium in vitro and in rabbits with experimental endocarditis. "
05/01/1997 - "Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis."
02/01/1995 - "In order to determine the microbiological and pharmacokinetic parameters that best predicted the in vivo antistaphylococcal activity of the streptogramin RP 59500 (quinupristin-dalfopristin), we evaluated the activity in rabbit aortic endocarditis of three regimens of quinupristin-dalfopristin against five strains of Staphylococcus aureus with various streptogramin B-type antibiotic resistance phenotypes and susceptible to streptogramin A-type antibiotics. "
07/01/2006 - "Optimal outpatient therapy for MRSA infections has yet to be determined, but this matter is complicated by the possibility of inducible macrolide-lincosamide-streptogramin B resistance (MLSBi). "
01/01/2013 - "Determination of antibiotic resistance of opportunistic Corynebacterium colonizing the nose that cause infections and evaluation of the applicability of a simple method for detecting the most common constitutive-type resistance to macrolides, lincosamides and streptogramin B (MLSB). "
|4.||Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
|5.||Soft Tissue Infections
|1.||Anti-Bacterial Agents (Antibiotics)